A world-first antipsychotic injectable drug developed in Perth will accelerate its path to market after the company behind it, Reliis, was acquired by a Melbourne biotechnology developer.
Emyjor Services managing director Greg Bowden was revealed as First Amongst Equals at the 40under40 Awards for 2024, winning first place ahead of a diverse cohort of WA's young business and community leaders.
